BVI announced an investment in augmented reality company Beyeonics Vision, a medical technology subsidiary of Elbit Systems Ltd.Terms of the deal were not disclosed.Beyeonics Vision uses integrated augmented reality, tracking, and image processing/AI platforms to deliver improved visualization, optimized workflow, and real-time support to surgeon decision-making process in the operating room, according to a company news release. The collaboration is …
AI-supported test can predict eye disease that leads to blindness
In a clinical trial of 113 patients led by researchers at Imperial College London and UCL, retinal imaging technology called Detection of Apoptosis in Retinal Cells (DARC) was able to identify areas of the eye that were showing signs of geographic atrophy (GA) – a common condition that causes reduced vision and blindness.The researchers believe that this technology could be …
Artificial intelligence may accurately identify glaucoma medication bottles
Artificial intelligence has demonstrated the ability to differentiate bottles of ophthalmic medications and could feasibly function on a smartphone platform, according to a study published in Ophthalmology Glaucoma. Researchers pretrained seven convolutional neural network (CNN) models to classify five common ophthalmic medications using a set of 2,250 images captured by mobile phones. The two top-performing networks were included in separate iOS …
Topcon Healthcare, RetInSight to Partner on AI Technology
Topcon Healthcare reported Aug. 3 that it would integrate the retina AI technology of RetInSight GmbH, of Austria, into its OCT devices and Harmony cloud-based data management technology under a new partnership. Financial details were not disclosed. The Oakland, New Jersey, company, part of Tokyo-based Topcon Corporation, said the move was designed to lead to improved clinical decision making and …
AI-based eye test could help prevent severe vision loss
Researchers from Imperial College London and University College London (UCL) carried out a clinical trial using retinal imaging technology known as Detection of Apoptosis in Retinal Cells (DARC). When tested on 113 patients in the trial, the technology was able to identify areas of the eye that were showing signs of geographic atrophy (GA) – a common condition that causes …
Eyenuk Raises $6.2 Million to Boost its EyeArt AI System to Screen for DR
Eyenuk, of Los Angeles, announced July 20 that it had completed a financing round of $6.2 million led by investment management company AXA IM, through AXA IM Alts, with existing investors also participating.
